Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer
Open Access
- 8 July 2022
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (8) , 102242
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (BX000792-06)
- US Department of Defense (W81XWH-19-10008)
This publication has 65 references indexed in Scilit:
- Tissue transglutaminase: a new target to reverse cancer drug resistanceAmino Acids, 2011
- Integrins in Cell MigrationCold Spring Harbor Perspectives in Biology, 2011
- Identification and Characterization of a Novel Integrin-Linked Kinase InhibitorJournal of Medicinal Chemistry, 2011
- Integrin Regulation of β-Catenin Signaling in Ovarian CarcinomaJournal of Biological Chemistry, 2011
- Role of Versican, Hyaluronan and CD44 in Ovarian Cancer MetastasisInternational Journal of Molecular Sciences, 2011
- Integrin‐linked kinase regulates migration and proliferation of human intestinal cells under a fibronectin‐dependent mechanismJournal of Cellular Physiology, 2009
- Application of a Global Proteomic Approach to Archival Precursor Lesions: Deleted in Malignant Brain Tumors 1 and Tissue Transglutaminase 2 Are Upregulated in Pancreatic Cancer PrecursorsPancreatology, 2008
- Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signalingCarcinogenesis, 2008
- Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinaseProceedings of the National Academy of Sciences, 2007
- Composition of the extracellular matrix of the peritoneumJournal of the Society for Gynecologic Investigation, 2001